Lenacapavir sodium
Lenacapavir (GS-6207) is a novel HIV-1 capsid inhibitor exhibiting picomolar in vitro potency (EC50 ~50 pM) against diverse subtypes with no cross-resistance. It demonstrates significant antiviral activity in clinical studies, supporting its research use in virology and antiretroviral development for both in vitro and in vivo applications.
Product Specifications
CAS Number
2283356-12-5
Field of Research
Infectious Disease & Virology, Protein Biochemistry
Smiles
FC (F) (C1=NN (CC (N[C@H] (C2=C (C3=C4C (C ([N-]S (C) (=O) =O) =NN4CC (F) (F) F) =C (C=C3) Cl) C=CC (C#CC (C) (C) S (C) (=O) =O) =N2) CC5=CC (F) =CC (F) =C5) =O) C6=C1[C@]7 ([H]) [C@@] (C (F) 6F) ([H]) C7) F.[Na+]
Molecular Formula
C39H31ClF10N7NaO5S2
Molecular Weight
990.26
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2912029-01 20 µg
Recombinant Bothriechis schlegelii NADH-ubiquinone oxidoreductase chain 4 (MT-ND4)
Sign In for Pricing
View Details orb2912029-02 100 µg
Recombinant Bothriechis schlegelii NADH-ubiquinone oxidoreductase chain 4 (MT-ND4)
Sign In for Pricing
View Details